INVEGA® receives European Commission approval to extend its adult indication for treatment of schizophrenia to include adolescents aged 15 years and older
- EMEA Innovative Medicine
- INVEGA® Receives European Commission Approval for Schizophrenia
INVEGA® Receives European Commission Approval for Schizophrenia
- X (Twitter)
Copy link